CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

LIMNLiminatus Pharma, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $3.73 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$250.51M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-14 · Valetudo Therapeutics LLC (10% Owner) · OTHER
  • 2026-07-06 · Valetudo Therapeutics LLC (10% Owner) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders15
Shares held1,019,379
Value$113.92K
Percent of shares outstanding1.52%
As of quarter end2026-06-30
RECENT NEWS
  • Liminatus Pharma regains Nasdaq compliance
  • Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Liminatus Pharma, Inc. (LIMN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit